Literature DB >> 25172595

The NF-κB, IRF3, and SAPK/JNK signaling cascades of animal immune cells and their role in the progress of type 1 diabetes mellitus.

E G Novoselova1, M O Khrenov, S B Parfenyuk, T V Novoselova, S M Lunin, E E Fesenko.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25172595     DOI： 10.1134/S0012496614040073

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN： 0012-4966


× No keyword cloud information.
  7 in total

1.  Triggering the interferon antiviral response through an IKK-related pathway.

Authors:  Sonia Sharma; Benjamin R tenOever; Nathalie Grandvaux; Guo-Ping Zhou; Rongtuan Lin; John Hiscott
Journal:  Science       Date:  2003-04-17       Impact factor: 47.728

2.  Nuclear factor kappa B (NF-κB): a novel cause for diabetes, coronary artery disease and cancer initiation and promotion?

Authors:  Nathaniel S Rial; Kwan Choi; Tam Nguyen; Branden Snyder; Marvin J Slepian
Journal:  Med Hypotheses       Date:  2011-10-19       Impact factor: 1.538

3.  NF-kappa B prevents beta cell death and autoimmune diabetes in NOD mice.

Authors:  Sunshin Kim; Isabelle Millet; Hun Sik Kim; Ja Young Kim; Myoung Sook Han; Moon-Kyu Lee; Kwang-Won Kim; Robert S Sherwin; Michael Karin; Myung-Shik Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-31       Impact factor: 11.205

4.  Nuclear factor kappaB protects pancreatic beta-cells from tumor necrosis factor-alpha-mediated apoptosis.

Authors:  Inik Chang; Sunshin Kim; Ja Young Kim; Namjoo Cho; Yun-Hee Kim; Hun Sik Kim; Moon-Kyu Lee; Kwang-Won Kim; Myung-Shik Lee
Journal:  Diabetes       Date:  2003-05       Impact factor: 9.461

5.  IRF3 contributes to sepsis pathogenesis in the mouse cecal ligation and puncture model.

Authors:  Wendy E Walker; Aaron T Bozzi; Daniel R Goldstein
Journal:  J Leukoc Biol       Date:  2012-10-09       Impact factor: 4.962

6.  IRF3 mediates a TLR3/TLR4-specific antiviral gene program.

Authors:  Sean Doyle; Sagar Vaidya; Ryan O'Connell; Hajir Dadgostar; Paul Dempsey; Ting Wu; Govinda Rao; Ren Sun; Margaret Haberland; Robert Modlin; Genhong Cheng
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

7.  Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study.

Authors:  Valma Harjutsalo; Lena Sjöberg; Jaakko Tuomilehto
Journal:  Lancet       Date:  2008-05-24       Impact factor: 79.321
  7 in total
  1 in total

1.  Peroxiredoxin 6 Attenuates Alloxan-Induced Type 1 Diabetes Mellitus in Mice and Cytokine-Induced Cytotoxicity in RIN-m5F Beta Cells.

Authors:  Elena G Novoselova; Olga V Glushkova; Sergey M Lunin; Maxim O Khrenov; Svetlana B Parfenyuk; Tatyana V Novoselova; Mars G Sharapov; Vladimir I Novoselov; Evgeny E Fesenko
Journal:  J Diabetes Res       Date:  2020-08-25       Impact factor: 4.011
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.